Search Results - Xiaofeng Cong

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Changing landscape of first-line treatment for locally advanced or metastatic urothelial carcinoma: the progression from platinum-based chemotherapy to platinum-free therapy

    Changing landscape of first-line treatment for locally advanced or metastatic urothelial carcinoma: the progression from platinum-based chemotherapy to platinum-free therapy by Zengguang Liu, Chen Chen, Jiaxin Yin, Xiaofeng Cong, Ziling Liu

    Published 2025-06-01

    Urothelial carcinoma (UC) represents the most common pathological type of bladder cancer. For patients with locally advanced or metastatic UC (la/m UC), the standard of care with platinum-based chemotherapy as the cornerstone has greatly improved the survival time. Although the platinum-containing r...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma

    Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma by Zengguang Liu, Xiaofeng Cong, Chen Chen, Jiaxin Yin, Ziling Liu

    Published 2025-07-01

    Overall survival (OS) in patients with advanced or metastatic urothelial carcinoma (UC) is not optimistic. For a long time, the standard platinum-based chemotherapy has been one of the preferred treatment strategies. Despite the high initial objective response rate (ORR) to first-line chemotherapy i...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: